Catalyst Wire Dossier Catalyst Wire Dossier

TRYVIO

APROCITENTAN · Idorsia Pharmaceuticals Ltd
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for TRYVIO, covering 2024-03-19 to 2026-08-06. Get the full timeline:

Most recent: FDA Approved: TRYVIO — Supplemental Application (Idorsia Pharmaceuticals Ltd)

See pricing